Approximately 40 million people worldwide are infected with human immunodeficiency virus. According to the CDC estimates, 1,144,500 people aged 13 years and older are living with HIV infection in the USA, with ~180,900 (15.8%) others infected but undiagnosed. The advent of combination antiretroviral therapy (cART; also known as highly active antiretroviral therapies, HAART) has transformed AIDS from a fatal illness into a chronic and manageable condition. Despite the success of cART, high prevalence of HIV-associated neurocognitive disorders (HAND) poses a major challenge for the society. It is estimated that 30-50% of individuals with HIV suffer from HAND, and approximately 350,000-575,000 cases in the United States alone HAND persist after cART likely due to the HIV infected microglia and macrophage reservoirs in the central nervous system and variable penetration of anti-retroviral drugs across the blood brain barrier. Additional factors such as CNS toxicity of cART, the aging of the brain, hepatitis C co-infection and substance abuse are known to exacerbate the symptoms of HAND. Methamphetamine (METH) is a psychostimulant drug that is chronically abused by an estimated 25 million people in the world. METH users exhibit an array of health complications ranging from agitation, anxiety, hypertension, psychosis and deficits in memory, attention and executive functions. Moreover, evidence suggests that METH can lead to neuroinflammation and neurodegeneration including loss of dopamine transporters, loss of serotonin transporters, increased dopamine levels, breakdown of the blood brain barrier. HAND and METH drug abuse are major health problems with huge socioeconomical burdens on society. Molecular mechanisms of HAND and METH are not well understood, partly due to the lack of physiologically relevant human model systems. Proposed work will develop pluripotent stem cell based cerebral organoid models and employ multidisciplinary approaches to investigate novel regulatory non-coding RNAs and epigenetics mechanisms, a nascent area in biology, of brain injury caused by HAND/METH. Because of their ability to self-organize and recapitulate many regenerative events seen in vivo, organoids present a human relevant, easily accessible, scalable model for disease pathogenesis and drug testing. Since we are able to control the microenvironment of organoid formation and maintenance, brain functions under various human conditions related to development, aging, and cART treatments can be studied. Results will be correlated with patients' data and drugs will be screened to rescue synaptic defects caused by HIV and METH.
Despite the success of combination antiretroviral therapy, high prevalence of HIV-associated neurocognitive disorders (HAND) poses a major challenge for the society. Additional factors such as aging of the brain, hepatitis C co-infection and Methamphetamine (METH) abuse are known to exacerbate the symptoms of HAND. This project proposes to develop pluripotent stem cell based cerebral organoid models and employ multidisciplinary approaches to investigate novel regulatory mechanisms of brain injury caused by HAND/METH.
| Yau, Edwin H; Rana, Tariq M (2018) Next-Generation Sequencing of Genome-Wide CRISPR Screens. Methods Mol Biol 1712:203-216 |
| Tiwari, Shashi Kant; Dang, Jason; Qin, Yue et al. (2017) Zika virus infection reprograms global transcription of host cells to allow sustained infection. Emerg Microbes Infect 6:e24 |
| Lichinchi, Gianluigi; Zhao, Boxuan Simen; Wu, Yinga et al. (2016) Dynamics of Human and Viral RNA Methylation during Zika Virus Infection. Cell Host Microbe 20:666-673 |
| Sansó, Miriam; Levin, Rebecca S; Lipp, Jesse J et al. (2016) P-TEFb regulation of transcription termination factor Xrn2 revealed by a chemical genetic screen for Cdk9 substrates. Genes Dev 30:117-31 |
| Mohammed, Idrees; Kummetha, Indrasena Reddy; Singh, Gatikrushna et al. (2016) 1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists. J Med Chem 59:7677-82 |
| Yang, Chao-Shun; Chang, Kung-Yen; Dang, Jason et al. (2016) Polycomb Group Protein Pcgf6 Acts as a Master Regulator to Maintain Embryonic Stem Cell Identity. Sci Rep 6:26899 |
| Zhou, Ying; Dang, Jason; Chang, Kung-Yen et al. (2016) miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3. Cancer Res 76:5777-5787 |
| Han, Tianxu; Yang, Chao-Shun; Chang, Kung-Yen et al. (2016) Identification of novel genes and networks governing hematopoietic stem cell development. EMBO Rep 17:1814-1828 |
| Xiong, Xiao-Peng; Kurthkoti, Krishna; Chang, Kung-Yen et al. (2016) miR-34 Modulates Innate Immunity and Ecdysone Signaling in Drosophila. PLoS Pathog 12:e1006034 |
| Gong, Danyang; Kim, Yong Hoon; Xiao, Yuchen et al. (2016) A Herpesvirus Protein Selectively Inhibits Cellular mRNA Nuclear Export. Cell Host Microbe 20:642-653 |
Showing the most recent 10 out of 12 publications
